Prostate carcinoma cells selected by long-term exposure to reduced oxygen tension show remarkable biochemical plasticity via modulation of superoxide, HIF-1α levels, and energy metabolism

Journal of Cellular Physiology

Volumn 212, Issue 3, 2007, Pages 744-752

  Bourdeau Heller, Jeanne ^a   Oberley, Terry D ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Veterans Administration Hospital   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEOXYGLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUPEROXIDE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; OXIDATION; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTON MOTIVE FORCE;

ADENOSINE TRIPHOSPHATE; ANTIMYCIN A; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ELECTRON TRANSPORT COMPLEX III; ENERGY METABOLISM; GLYCOLYSIS; HOMEOSTASIS; HUMANS; HYPEROXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXYGEN; OXYGEN CONSUMPTION; PROSTATIC NEOPLASMS; SUPEROXIDES; TIME FACTORS; UNCOUPLING AGENTS;

EID: 34547944780     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21069     Document Type: Article

References (50)

1. Ataullakhanov FI, Vitvitsky VM. 2002. What determines the intracellular ATP concentration. Biosci Rep 22:501-511.
2. BelAiba RS, Djordjevic T, Bonello S, Fluegel D, Hess J, Kietzmann T, Gorlach A. 2004. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol Chem 385:249-257.
3. Brand K. 1997. Aerobic glycolysis by proliferating cells: Protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 29:355-363.
4. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, Scarpulla RC, Chandel NS. 2005. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metabolism 1:409-414.
5. Capuano F, Guerrieri F, Papa S. 1997. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J Bioenerg Biomembr 29:379-384.
6. Chandel NS, McClintock DS, Feliciano CE, Wood TM. Melendez JA, Rodriguez AM, Schumacker PT. 2000. Reactive oxygen species generated at mitochondrial Complex III stabilize hypoxia-inducible factor-1α during hypoxia. J Biol Chem 275:25130-25138.
7. Covi JA, Treleaven WD, Hand SC. 2005. V-ATPase inhibitin prevents recovery from anoxia in Artemia franciscana embryos: Quiescence signaling through dissipation of proton gradients. J Exp Biol 208:2799-2808.
8. D'Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. 2006. Low oxygen tension inhibits osteogenic differentiation and enhances sternness of human MIAMI cells. Bone 39:513-522.
9. Doege K, Heine S, Inga J, Jelkmann W, Metzen E. 2005. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106:2311-2317.
10. Freshney RI. 1994. Growth cycle. In: Freshney RI, editor. Culture of Animal Cells A Manual of Basic Techniques 3rd ed. New York: Wiley-Liss. p 279-282.
11. Ghafar MA, Anastasiadis AG, Chen MW, Burchardt M, Olsson LE, Xie H, Benson MC, Buttyan R. 2003. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 54:58-67.
12. Guppy M. 2002. The hypoxic core: A possible answer to the cancer paradox. Biochem Biophys Res Commun 299:676-680.
13. Guzy RD, Schumacker PT. 2006. Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807-819.
14. Hajeri VA, Trejo J, Padilla PA. 2005. Characterization of sub-nuclear changes in Caenorhabditis elegans embryos exposed to brief, intermediate and long-term anoxia to analyze anoxia-induced cell cycle arrest. BMC Cell Biol 6:1471-2121.
15. Halliwell B, Whiteman M. 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 142:231-255.
16. Halvey PJ, Watson WH, Hansen JM, Mi Go Y, Samali A, Jones DP. 2005. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signaling. Biochem J 386:215-219.
17. Harris M. 1964. Cell Culture and Somatic Variation. Chicago: Holt, Rinehardt and Winston.
18. Hochachaka PW, Rupert JL, Goldenberg L, Gleave M, Kozlowski P. 2002. Going malignant: The hypoxia-cancer connection in the prostate. Bioessays 24:749-757.
19. Hoffman DL, Salter JD, Brookes PS. 2006. The response of mitochondrial reactive oxygen species generation to steady-state oxygen tension: Implications for hypoxic cell signaling. Am J Physiol Heart Circul Physiol (Epub ahead of print).
20. Holmquist L, Jogi A, Pahllman S. 2005. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int J Cancer 116:218-225.
21. Kaftan EJ, Xu T, Abercrombie R, Hille B. 2000. Mitochondria shape hormonally induce cytoplasmic calcium oscillations and modulate exocytosis. J Biol Chem 275:25465-25470.
22. Kim J-w, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism 3:177-185.
23. Kino-oka M, Agatahama Y, Haga Y, Inoie M, Taya M. 2005. Long-term subculture of human keratinocytes under an anoxic condition. J Biosci Bioeng 100:119-122.
24. 2 by mitochondria in the resting state. FEBS Lett 435:215-218.
25. Land SC. 2004. Hochachka's "Hypoxia defense strategies" and the development of the pathway for oxygen. Comparative Biochem Physiol 139 (Part B):415-433.
26. Li N, Oberley TD. 1998. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J Cell Physiol 177:148-160.
27. Li N, Oberley TD, Oberley LW, Zhong W. 1998. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 35:221-233.
28. Liu SS. 1997. Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci Rep 17:259-272.
29. Mathupala SP, Rempel A, Pedersen PL. 1997. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role of type II hexokinase. J Bioenerg Biomembr 29:339-343.
30. Mendenhall AR, Larue B, Padilla PA. 2006. Glyceraldehyde-3-phosphate dehydrogenase mediates anoxia response and survival in Caenorhabditis elegans. Genetics (Epub ahead of print).
31. Menon SG, Sarsour EH, Spitz DR, Higashikubo R, Sturm M, Zhang H, Goswami PC. 2003. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res 63:2109-2117.
32. Morre DJ. 2004. Quinone oxidoreductase of the plasma membrane. In: Sies H, Packer L. editors. Quinones and Quinone Enzymes. San Diego: Elsevier Academic Press. p 179-199.
33. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C. 2003. Regulation of HIF-1a protein level during hypoxic conditions by the PICK/AKT/GSK3B pathway in HepG2 cells. J Biol Chem 278:31277-31285.
34. Movsas B, Chapman D, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. 2001. Hypoxia in human prostate carcinoma. Am J Clin Oncol 24:458-461.
35. Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. 1999. Hypoxic regions exist in human prostate carcinoma. Urology 53:11-18.
36. Mozo J, Fery G, Studeny A, Pecqueur C, Rodriguez M, Boutin JA, Bouillaud F. 2005. Expression of UCP3 in CHO cells does not cause uncoupling but controls mitochondrial activity in the presence of glucose. Biochem J 93:431-439.
37. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively down regulating mitochondrial oxygen consumption. Cell Metabolism 3:187-197.
38. Paul SAM, Simons JW, Mabjeesh NJ. 2004. HIF at the cross roads between ischemia and carcinogenesis. J Cell Physiol 200:20-30.
39. Piraut JL, Lopez-Barneo J. 2005. Oxygen tension regulates mitochondrial DNA-encoded Complex I gene expression. J Biol Chem 280:42676-42684.
40. Schmalhausen EV, Muronetz VI. 1997. An uncoupling of the processes of oxidation and phosphorylation in glycolysis. Biosci Rep 17:521-527.
41. Schroedl C, McClintock DS, Budinger GRS, Chandel NS. 2002. Hypoxic but not anoxic stabilization of HIF-1 alpha requires mitochondrial reactive oxygen species. Am J Physiol, Lung Cell Mol Physiol 283:L922-931.
42. Semenza GL, Artemov D, Bedi A, Bhujwalla Z, Chiles K, Feldser D, Laughner E, Ravi R, Simons JW, Taghavi P, Zhong H. 2001. 'The metabolism of tumours': 70 years later. Novartis Foundation Symp 240:251-260.
43. Silva JP, Shabalina IG, Dufour E, Petrovic N, Backlund EC, Hultenby K, Wibom R, Nedergaard J, Cannon B, Larsson N-G. 2005. 5OD2 overexpression: Enhanced mitochondrial tolerance but absence of the effect on UCP activity. EMBO J: 1-10.
44. Turrens JF. 2003. Mitochondrial formation of reactive oxygen species. J Physiol 5S2:335-344.
45. Vaupel P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Sem Radiat Oncol 14:198-206.
46. Warburg O. 1930. The Metabolism of Tumors. London: Constable.
47. Xu R-h, Pelicano H, Zhou Y, Carew JS, Feng L, Bhaffa KN, Keating MJ, Huang P. 2005. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65:613-621.
48. Yancik R. 2005. Population aging and cancer: A cross-national concern. Cancer J 11:437-441.
49. Zhang Z, Karam J, Frenkel E, Saglowsky A, Hsieh JT. 2006. The application of epigenetic modifiers on the treatment of prostate and bladder cancer. Urol Oncol 24:152-160.
50. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, Kalyanaraman B. 2003. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: Potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 35:1359-1368.